Effect of Oxygen on the Cytotoxicity and Antitumor Activity of Etoposide2
- 1 December 1985
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 75 (6) , 1129-1133
- https://doi.org/10.1093/jnci/75.6.1129
Abstract
The selective cytotoxicity of the epipodophyllotoxin etoposide toward normally oxygenated and hypoxic EMT6 mouse mammary tumor cells in culture was examined. Etoposide was much more toxic to normally oxygenated cells. The ratio (hypoxic to oxygenated) of drug concentrations producing 1 log of cell kill was approximately 30:1. Established FSa-IIC fibrosarcomas of C3HeB/FeJ mice were treated with 10, 15, or 20 mg etoposide/kg body weight in a 6-day protocol. Fluosol-DA with or without breathing of carbogen (i.e., 95% O2-5% CO2) was added to the treatment program on days 1, 3, and 5. The combination of etoposide-Fluosol-DA-carbogen markedly enhanced tumor growth delay compared to the result with etoposide alone. The dose-modifying effect observed was 1.9±0.3. With the use of both single-dose and multiple-dose protocols for etoposide and Fluosol-DA with air or carbogen breathing, the survival of bone marrow cells was measured by colony formation in vitro (granulocyte-monocyte colony-forming units). Fluosol-DA and carbogen breathing did not increase the toxicity of etoposide to the bone marrow. Thus the enhancement in antitumor activity produced by the addition of Fluosol-DA and carbogen breathing to etoposide treatment was not accompanied by a concomitant increase in normal tissue toxicity and represents an increase in the therapeutic efficacy of etoposide.Keywords
This publication has 15 references indexed in Scilit:
- Perfluorochemical Emulsions Can Increase Tumor RadiosensitivityScience, 1984
- Ataxia-Telangiectasia: A Multisystem Hereditary Disease with Immunodeficiency, Impaired Organ Maturation, X-Ray Hypersensitivity, and a High Incidence of NeoplasiaAnnals of Internal Medicine, 1983
- EFFECTS OF THE EPIPODOPHYLLOTOXIN VP-16-213 ON CELL-CYCLE TRAVERSE, DNA-SYNTHESIS, AND DNA STRAND SIZE IN CULTURES OF HUMAN-LEUKEMIC LYMPHOBLASTS1983
- EFFECTS OF THE DNA STRAND-CLEAVING ANTI-TUMOR AGENT, STREPTONIGRIN, ON ATAXIA TELANGIECTASIA CELLS1983
- DNA DAMAGE AS A BASIS FOR 4'-DEMETHYLEPIPODOPHYLLOTOXIN-9-(4,6-O-ETHYLIDENE-BETA-D-GLUCOPYRANOSIDE) (ETOPOSIDE) CYTO-TOXICITY1983
- CELLULAR-HYPERSENSITIVITY TO NEOCARZINOSTATIN IN ATAXIA-TELANGIECTASIA SKIN FIBROBLASTS1982
- The response of ataxia-telangiectasia homozygous and heterozygous skin fibroblasts to neocarzinostatinCarcinogenesis: Integrative Cancer Research, 1981
- CLASSIFICATION OF ANTI-NEOPLASTIC AGENTS BY THEIR SELECTIVE TOXICITIES TOWARD OXYGENATED AND HYPOXIC TUMOR-CELLS1981
- UNUSUAL SENSITIVITY OF ATAXIA TELANGIECTASIA CELLS TO BLEOMYCIN1979
- Effect of VP-16-213 on the intracellular degradation of DNA in HeLa cellsBiochemistry, 1976